Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

During the Trading Day
16.63 -1.39 / -7.71%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.63 0.00 / 0.00%
 
Volume: 3.8K

Today’s Trading

Previous close18.02
Today’s open17.18
Day’s range16.34 - 17.54
Volume1,662,011
Average volume (3 months)1,926,357
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+18.40%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book20.45

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.84+1.50%
MCRBSeres Therapeutics I...+1.06+2.80%
MNTAMomenta Pharmaceutic...+0.02+0.09%
ESPREsperion Therapeutic...-1.15-1.85%
Data as of 3:59pm ET, 08/03/2015

Financials

Last reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts